HCPCS Level IIdrugActive
J9316
Pertuzu, trastuzu, 10 mg
BETOS: O1D
Effective: 2021-01-01
Description
Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Phesgo
Manufacturer
Genentech, Inc.
HCPCS Dosage
10 MG
Billing Units
180.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.